FDA Clears Two New Oral Drugs for Hepatitis C FDA Clears Two New Oral Drugs for Hepatitis C

Technivie, for genotype 4 infection, combines ombitasvir, paritaprevir, and ritonavir and is for use with ribavirin. Daclatasvir, for use with sofosbuvir, is for genotype 3 infection. FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Alert Source Type: news